The study findings include: By week 120, participants who were previously on semaglutide regained two-thirds of their body weights after a year without receiving the maximum dose of Wegovy (2.4 mg weekly) Similarly, cardiometabolic improvements from week 0 to week 68 from semaglutide also declined at week 120
A more conservative approach suggests ~25%
Yes, you can, but in small amounts
Visible particles: Floating particles, crystals, or sediment indicate the medication has degraded or been contaminated
Higher protein intake may help preserve lean mass
Medically assisted weight loss at Le Spa uses GLP-1 receptor agonist therapyincluding Semaglutide (the active ingredient in Ozempic and Wegovy) and Tirzepatide (the active ingredient in Mounjaro and Zepbound)to help patients achieve meaningful, sustainable weight loss under medical supervision